









Markets
/
Stocks
/
nasdaq-cntb
/

Connect Biopharma Holdings Ltd

CNTB

2.530USD

+0.260+11.45%

Market hours （ET）Quotes delayed by 15 min

141.14MMarket Cap

LossP/E TTM



Connect Biopharma Holdings Ltd

2.530

+0.260+11.45%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Cash Flow Statement

You can access the annual and quarterly cash flow statements of Connect Biopharma Holdings Ltd to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q1

FY2024H1

FY2023H1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

---17.41M

---12.59M

-1585.11%-9.96M

---591.00K

74.41%-7.97M

---31.16M

Net income from continuing operations

---17.20M

---12.90M

-18.16%-10.27M

---8.69M

125.35%7.71M

---30.41M

Operating gains losses

--179.00K

--171.00K

5.49%173.00K

--164.00K

-6.11%476.00K

--507.00K

Other non-cash items

---169.00K

---288.00K

-179.78%-249.00K

---89.00K

96.19%-17.00K

---446.00K

Change in working capital

---1.13M

---526.00K

-108.75%-587.00K

--6.71M

-833.77%-17.89M

---1.92M

-Change in receivables

---17.00K

--8.00K

--781.00K

--0.00

-900.93%-3.21M

---321.00K

-Change in prepaid expenses

---1.81M

---2.24M

-206.53%-1.29M

--1.21M

----

-Change in payables and accrued expense

----

390.15%589.00K

---203.00K

-Change in other current assets

--1.00K

--2.00K

-800.00%-9.00K

---1.00K

104.74%23.00K

---485.00K

-Change in other current liabilities

---3.00K

---505.00K

-100.08%-5.00K

--6.62M

-2620.61%-13.33M

---490.00K

Cash from non-recurring investing activities

Cash from operating activities

---17.41M

---12.59M

-1585.11%-9.96M

---591.00K

74.41%-7.97M

---31.16M

Investing cash flow

Net cash from continuing investing activities

--34.00K

--303.00K

--79.00K

--0.00

50.87%436.00K

--289.00K

Capital expenditures

--34.00K

--303.00K

--81.00K

--0.00

50.87%436.00K

--289.00K

Net cash flow from disposal of fixed assets

--34.00K

--303.00K

--79.00K

--0.00

50.87%436.00K

--289.00K

Net cash flow from investment products

--14.38M

--5.43M

-322.29%-20.56M

--9.25M

-62.93%12.76M

--34.41M

Net cash flow from other investing activities

--0.00

----

-25.71%-44.00K

---35.00K

Cash from non-current investing activities

Net cash flow from investing activities

--14.35M

--5.13M

-323.15%-20.64M

--9.25M

-63.98%12.28M

--34.09M

Financing cash flow

Cash flow from continuous financing activities

--215.00K

--161.00K

--2.00K

--0.00

62.30%-46.00K

---122.00K

Net cash flow from debt Issuance/repayment

----

-2.78%-148.00K

---144.00K

Net cash flow from common stock issuance/repurchase

--0.00

--143.00K

----

-9.09%20.00K

--22.00K

Proceeds from stock option exercised by employees

--215.00K

--18.00K

--2.00K

--0.00

--82.00K

--0.00

Net cash flow from other financing activities

--0.00

----

Net cash from non-recurrent financing activities

Net cash from financing activities

--215.00K

--161.00K

--2.00K

--0.00

62.30%-46.00K

---122.00K

Net cash flow

Beginning cash balance

--40.63M

--47.71M

-25.96%78.23M

--105.66M

34.17%106.01M

--79.01M

Current period cash flow changes

---2.79M

---7.08M

-461.73%-30.52M

--8.44M

60.33%4.17M

--2.60M

Effect of exchange rate changes

--58.00K

--224.00K

133.94%75.00K

---221.00K

57.55%-90.00K

---212.00K

Ending cash balance

--37.84M

--40.63M

-58.19%47.71M

--114.10M

35.00%110.17M

--81.61M

Free cash flow

---17.44M

---12.89M

-1598.82%-10.04M

---591.00K

73.25%-8.41M

---31.44M

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

